Arkolith/Insider Trading/NARI/Form 4

Hykes Andrew

President and CEO, DirectorInari Medical, Inc. (NARI) · full profile →Form 4 · filed Feb 19, 2025
No Open-Market Flow
Open-Market Buys
$0
Open-Market Sells
$0
Net Open-Market Flow
$0
Transactions
8
6 non-derivative · 2 derivative

Non-Derivative Transactions (Table I)

DateActionSharesPriceValueOwned After
Feb 19, 2025Tender(U)1K——0
Feb 19, 2025Tender(U)2K——0
Feb 19, 2025Tender(U)2K——0
Feb 19, 2025Tender(U)2K——0
Feb 19, 2025Grant(A)20K——718K
Feb 19, 2025Tender(U)718K——0

Derivative Transactions (Table II)

DateActionSharesPriceValueOwned After
Feb 19, 2025Disposed to issuer(D)36K——0
Feb 19, 2025Disposed to issuer(D)45K——0

Transaction Codes

U
See SEC Form 4 code table
A
Grant / award
D
Disposition to the issuer

Data Source & Provenance

Parsed from a single SEC EDGAR Form 4 filing (accession 0001127602-25-005734) within minutes of acceptance. Every field above traces to the original document. Verify it directly:

View original filing on SEC.govRaw Form 4 XML